DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Sherwood MW, Douketis JD, Patel MR. , et al; ROCKET AF Investigators.
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).
Circulation 2014;
129 (18) 1850-1859
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.